Back to company

OBA-PHARMA ApS: Financial statements 2017

CVR: 19995607

OBA-PHARMA ApS (CVR 19995607) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 2,770,857 and a net result of DKK 2,155,159 compared with DKK 2,206,997 the year before. That is a decrease of 1.4% compared with the year before. Equity amounted to DKK 4,428,544. The solvency ratio was 66.1%.

Gross Profit
2,770,857 kr.
Profit/Loss
2,155,159 kr.
Equity
4,428,544 kr.
Total Assets
6,698,747 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017-2.8 mio.2.2 mio.4.4 mio.-
2016-2.8 mio.2.2 mio.2.8 mio.-
2015-3.2 mio.2.5 mio.3.1 mio.-
2014-3.7 mio.3.1 mio.3.6 mio.-
2013-2.9 mio.2.4 mio.3 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like OBA-PHARMA ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2017

OBA-PHARMA ApS: The 2016 annual report is outFeb 20, 2017

OBA-PHARMA ApS has published its annual report for 2016. Gross profit came to DKK 2,809,440, and the net result was DKK 2,206,997.

OBA-PHARMA ApS appoints new auditorFeb 3, 2017

As of February 3, 2017, BHA STATSAUTORISERET REVISION APS has been appointed auditor of OBA-PHARMA ApS.

About OBA-PHARMA ApS

OBA-PHARMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 1997. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named PBH 25.376 ApS. The management consists of Malene Dybdahl Birch. The company is owned by LEV-VEL ApS and NLDB Holding ApS. The company has 0 employees. In 2024, the company reported a gross profit of DKK 3,402,201 and a net result of DKK 2,670,973 compared with DKK 2,073,440 the year before. Equity amounted to DKK 674,251.